P. Bailey, D. K. Chang, K. Nones, A. L. Johns, A. Patch et al., Genomic analyses identify molecular subtypes of pancreatic cancer, Australian Pancreatic Cancer Genome Initiative, vol.531, pp.47-52, 2016.

J. Barr, M. Vá-zquez-chantada, C. Alonso, M. Pé-rez-cormenzana, R. Mayo et al., Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated, 2010.

H. Tian, C. A. Callahan, K. J. Dupree, W. C. Darbonne, C. P. Ahn et al., Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis, Proc. Natl. Acad. Sci. USA, vol.106, pp.4254-4259, 2009.

M. Topalovski and R. A. Brekken, Matrix control of pancreatic cancer: new insights into fibronectin signaling, Cancer Lett, vol.381, pp.252-258, 2016.

E. C. Townsend, M. A. Murakami, A. Christodoulou, A. L. Christie, J. Kö-ster et al., The public repository of xenografts enables discovery and randomized phase II-like trials in mice, Cancer Cell, vol.29, pp.574-586, 2016.

T. Ueki, M. Toyota, T. Sohn, C. J. Yeo, J. P. Issa et al., Hypermethylation of multiple genes in pancreatic adenocarcinoma, Cancer Res, vol.60, pp.1835-1839, 2000.

E. J. Walker, A. H. Ko, E. A. Holly, and P. M. Bracci, Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study, Cancer, vol.121, pp.1287-1294, 2015.

C. Whatcott, H. Han, R. G. Posner, V. Hoff, and D. D. , Tumor-stromal interactions in pancreatic cancer, Crit. Rev. Oncog, vol.18, pp.135-151, 2013.

A. K. Witkiewicz, E. A. Mcmillan, U. Balaji, G. Baek, W. Lin et al., Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets, Nat. Commun, vol.6, p.6744, 2015.

A. K. Witkiewicz, U. Balaji, C. Eslinger, E. Mcmillan, W. Conway et al., Integrated patientderived models delineate individualized therapeutic vulnerabilities of pancreatic cancer, Cell Rep, vol.16, pp.2017-2031, 2016.

B. U. Wu, J. Chang, C. Y. Jeon, S. J. Pandol, B. Huang et al., Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer, Am. J. Gastroenterol, vol.110, pp.1233-1239, 2015.

, Cell Reports, vol.21, 2017.

, Cell Reports, vol.21

, Supplemental Information Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

R. Nicolle, Y. Blum, L. Marisa, C. Loncle, O. Gayet et al.,

R. A. Moffitt, Virtual microdissection identifies distinct tumor-and stromaspecific subtypes of pancreatic ductal adenocarcinoma, Nature Genetics, vol.47, pp.1168-1178, 2015.

P. Bailey, Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016.

T. Conway, Xenome-a tool for classifying reads from xenograft samples, Bioinformatics, vol.28, pp.172-180, 2012.

G. Banneau, P. M. Ayadi, L. Armenoult, and E. Carvalho, Homogenization of cartilage tumors to extract total RNA to microarray and sequencing analysis using Precellys bead-beating technology, BioTechniques, vol.52, pp.196-197, 2012.

H. Li, Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM, 2013.

A. Mckenna, The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data, Genome Research, vol.20, pp.1297-1303, 2010.

G. A. Van-der-auwera, From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline, Curr Protoc Bioinformatics, vol.43, 2013.

K. Cibulskis, Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nature Biotechnology, vol.31, pp.213-219, 2013.

K. Wang, M. Li, and H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res, vol.38, pp.164-164, 2010.

J. Staaf, Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios, BMC Bioinformatics, vol.9, p.409, 2008.

E. S. Venkatraman and A. B. Olshen, A faster circular binary segmentation algorithm for the analysis of array CGH data, Bioinformatics, vol.23, pp.657-663, 2007.

T. Popova, Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays, Genome Biol, vol.10, p.128, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00663915

M. Toyota, CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sci. U.S.A, vol.96, pp.8681-8686, 1999.

K. Nones, Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling, Int. J. Cancer, vol.135, pp.1110-1118, 2014.

F. Vigneault, High-throughput multiplex sequencing of miRNA, Curr Protoc Hum Genet Chapter, 2012.

G. Barturen, sRNAbench: profiling of small RNAs and its sequence variants in single or multi-species high-throughput experiments, Methods in Next Generation Sequencing, vol.1

J. H. Bullard, E. Purdom, K. D. Hansen, and S. Dudoit, Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments, BMC Bioinformatics, vol.11, p.94, 2010.

A. Dobin, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, pp.15-21, 2013.

Y. Liao, G. K. Smyth, and W. Shi, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features, Bioinformatics, vol.30, pp.923-930, 2014.

J. Carlevaro-fita, A. Rahim, R. Guigó, L. A. Vardy, and R. Johnson, Cytoplasmic long noncoding RNAs are frequently bound to and degraded at ribosomes in human cells, RNA, vol.22, pp.867-882, 2016.

E. Becht, Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy, Clinical Cancer Research, vol.22, pp.4057-4066, 2016.

M. D. Wilkerson and D. N. Hayes, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking, Bioinformatics, vol.26, pp.1572-1573, 2010.

C. W. Law, Y. Chen, W. Shi, and G. K. Smyth, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol, vol.15, p.29, 2014.

J. F. Cardoso and A. Souloumiac, Blind beamforming for non-Gaussian signals, IEE Proceedings F-Radar and Signal Processing, vol.140, pp.362-370, 1993.

E. A. Collisson, Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy, Nature Medicine, vol.17, pp.500-503, 2011.

L. Marisa, Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, vol.10, p.1001453, 2013.

J. Guinney, The consensus molecular subtypes of colorectal cancer, Nature Medicine, vol.21, pp.1350-1356, 2015.

J. Barr, Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease, J. Proteome Res, vol.9, pp.4501-4512, 2010.

J. Barr, Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression, J. Proteome Res, vol.11, pp.2521-2532, 2012.

I. Martínez-arranz, Enhancing metabolomics research through data mining, J Proteomics, vol.127, pp.275-288, 2015.

F. S. Schreiber, Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RASG12V oncogene, Gastroenterology, vol.127, pp.250-260, 2004.

L. Huang, Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell-and patient-derived tumor organoids, Nature Medicine, vol.21, pp.1364-1371, 2015.

S. Giusiano, Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk, Int. J. Oncol, vol.36, pp.889-898, 2010.

C. Charpin, Validation of an immunohistochemical signature predictive of 8year outcome for patients with breast carcinoma, Int. J. Cancer, vol.131, pp.236-279, 2012.